Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H M Engbers

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Anaesthesia|February 1, 2018
Anomalies in target-controlled infusion: an analysis after 20 years of clinical useF H M Engbers, A Dahan
Anaesthesia|December 20, 2015
The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusionJ B Glen, F H M Engbers
British Journal of Anaesthesia|January 23, 2003
Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesiaM J Mertens, F H M Engbers, A G L Burm, et al.
Anaesthesia|April 18, 2014
A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofolA J Thomson, A F Nimmo, F H M Engbers, et al.
Acta Anaesthesiologica Belgica|March 11, 2014
Tips and tricks to optimize total intravenous anesthesiaL Barvais, F A Lobo, F H M Engbers, et al.
Perfusion|August 3, 2014
Sevoflurane-enriched blood cardioplegia: the intramyocardial delivery of a volatile anestheticA van der Baan, K A Kortekaas, E van Es, et al.
British Journal of Anaesthesia|March 6, 2014
Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repairK A Kortekaas, A van der Baan, L P H J Aarts, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anaesthesia|February 1, 2018
Anomalies in target-controlled infusion: an analysis after 20 years of clinical useF H M Engbers, A Dahan
Anaesthesia|December 20, 2015
The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusionJ B Glen, F H M Engbers
British Journal of Anaesthesia|January 23, 2003
Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesiaM J Mertens, F H M Engbers, A G L Burm, et al.
Anaesthesia|April 18, 2014
A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofolA J Thomson, A F Nimmo, F H M Engbers, et al.
Acta Anaesthesiologica Belgica|March 11, 2014
Tips and tricks to optimize total intravenous anesthesiaL Barvais, F A Lobo, F H M Engbers, et al.
Perfusion|August 3, 2014
Sevoflurane-enriched blood cardioplegia: the intramyocardial delivery of a volatile anestheticA van der Baan, K A Kortekaas, E van Es, et al.
British Journal of Anaesthesia|March 6, 2014
Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repairK A Kortekaas, A van der Baan, L P H J Aarts, et al.
Pageof 1